Global Intravenous Fluid Bags Market 2018-2022
About Intravenous Fluid Bags
Intravenous fluids are used to store intravenous solutions for administering nutrition and medication intravenously for correcting electrolyte imbalance in patients.
Technavio’s analysts forecast the global intravenous fluid bags market to grow at a CAGR of 5.56% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous fluid bags market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of intravenous fluid bags.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Intravenous Fluid Bags Market 2018-2022
Technavio recognizes the following companies as the key players in the global intravenous fluid bags market: B. Braun Melsungen, Baxter International , Fresenius , JW Life Science, Pfizer (Hospira), Sippex IV bag
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Continuous product innovation. Manufactures are constantly improving the features of intravenous fluid bags. One such innovation involves alternative to PVC products. PVC and its toxic breakdown product, and DEHP have an adverse effect on patient's health. As a result, there has been an increase in the usage of disposable or single-use intravenous bags.”
According to the report, one of the major drivers for this market is Growing demand for intravenous therapy due to increased prevalence of chronic diseases. There has been an exponential rise in chronic diseases such as cancer, diabetes, and CVDs owing to factors such as an increase in urbanization, sedentary lifestyle, and unbalanced diet. According to the CDC, in 2014, in the US, 1,596,486 people were diagnosed with cancer, of which, 591,686 people died. Cancer patients face complications such as malnutrition, acute weight loss, and anorexia. These conditions affect the fluid balance and cause instability that leads to the higher mortality rate in patients.
Further, the report states that one of the major factors hindering the growth of this market is Concerns related to plastic intravenous bags. Innovation in intravenous products involves new materials for medical devices and products. There has been a shift from glass bottles to plastic bags made from low density polyethylene and high-density polyethylene. These plastic products might be easy to use and economically priced but carry a high risk of contamination. Plastic products result in leaching of chemicals from lacquers, paper or film face stocks, adhesives, topcoats, label inks, or even the bags itself.
B. Braun Melsungen, Baxter International , Fresenius , JW Life Science, Pfizer (Hospira), Sippex IV bag